id: NEW:antiretroviral_therapy_adherence_to_NEW:hiv_disease_progression
name: Antiretroviral Therapy Adherence â†’ HIV Disease Progression
from_node:
  node_id: NEW:antiretroviral_therapy_adherence
  node_name: Antiretroviral Therapy Adherence
to_node:
  node_id: NEW:hiv_disease_progression
  node_name: HIV Disease Progression
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Adequate antiretroviral therapy adherence maintains drug levels to suppress viral replication'
- 'Step 2: Viral suppression prevents ongoing destruction of CD4+ T cells'
- 'Step 3: Preserved immune function prevents opportunistic infections and AIDS-defining conditions'
- 'Step 4: Disease progression to advanced HIV/AIDS stages is slowed or prevented'
evidence:
  quality_rating: A
  n_studies: 53
  primary_citation: 'Jessica de Mattos Costa et al. 2018. "Adherence to antiretroviral therapy for HIV/AIDS
    in Latin America and the Caribbean: Systematic review and meta-analysis.." https://doi.org/10.1002/jia2.25066'
  supporting_citations:
  - Additional citations require full-text access - meta-analysis included 53 studies from 25 Latin American
    and Caribbean countries
  - Studies published between 2005 and 2016
  - Individual study citations available in full-text systematic review
  doi: 10.1002/jia2.25066
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The meta-analysis establishes that optimal ART adherence slows HIV disease progression. With
  only 70% adherence observed across the region, many patients may experience accelerated disease progression
  due to suboptimal viral suppression.
quantitative_effects:
  effect_size:
    value: 70.0
    type: percentage_change
    ci_lower: 63.0
    ci_upper: 76.0
  sample_size: 22603
spatial_variation:
  varies_by_geography: true
  variation_notes: Setting-specific factors across 25 Latin American and Caribbean countries influence
    adherence and likely disease progression outcomes
moderators:
- name: regional_healthcare_infrastructure
  direction: strengthens
  strength: moderate
  description: Variable healthcare system capacity across Latin American and Caribbean countries affects
    ability to support adherence
structural_competency:
  equity_implications: Disease progression in HIV is directly tied to healthcare system capacity to support
    medication adherence. Structural factors including healthcare access, medication supply chains, and
    social determinants unique to Latin American and Caribbean settings create differential vulnerability
    to disease progression that cannot be attributed to individual behavior alone.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.361718'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
